Daaweynta Kansarka Kelyaha
1 / 3

Daaweynta Kansarka Kelyaha Qiimaha Hindiya

4,000 USD to 18,000 USD
Maalmaha cisbitaalka4
Maalmo ka baxsan isbitaalka15
Nidaamka nidaamka 180 daqiiqado
Heerka guusha85%-95%
Na soo celi
Na soo celi

Ku saabsan Daaweynta Kansarka Kelyaha

Kansarka kelyuhu waa mid ka mid ah kansarrada sida aadka ah u koraya ee adduunka oo dhan, kaas oo saameeya ragga iyo dumarkaba, gaar ahaan marka ay da'doodu tahay 50 jir. Warbixinnada caafimaadka adduunka ayaa muujinaya kor u kac joogto ah oo ku saabsan kiisaska cusub sannad kasta, oo ay ugu horrayn sabab u tahay hagaajinta sawir-qaadista iyo arrimaha khatarta ah ee la xiriira hab-nololeedka. Inkasta oo ay inta badan si aamusnaan ah u korto, daawaynta casriga ahi waxay si aad ah u wanaajisay badbaadada iyo natiijooyinka muddada dheer.

 

Ogaanshaha hore waxay keenaysaa farqi weyn. Marka dhakhaatiirtu ay ogaadaan kansarka kelyaha marxaladda hore, bukaanku waxay inta badan si fiican uga jawaabaan qalliinka ama daaweynta la beegsanayo. Horumarrada laga sameeyay robotics-ka, dawooyinka saxda ah, iyo farsamooyinka ugu yar ee wax-soo-saarka, shakhsiyaad badan ayaa hadda ku soo noqda hawlahooda caadiga ah iyagoo wata raaxo iyo kalsooni wanaagsan.

 

Waa maxay Kansarka Kelyuhu?

Kansarka kelyuhu wuxuu bilaabmaa marka unugyada aan caadiga ahayn ay si aan la xakamayn karin ugu koraan hal ama labada kelyood. Xubnahan ayaa qashinka ka sifeeya dhiigga waxayna caawiyaan ilaalinta dheelitirka dareeraha, si ay burooyinku farageliyaan hawlaha muhiimka ah ee jidhka. Kansarrada kelyaha intooda badani waxay ka bilaabmaan qaybaha yar yar ee shaandhaynta kelyaha, iyagoo si tartiib tartiib ah u samaysanaya tiro laga yaabo inay fidaan haddii aan la daweyn.

 

Kansarka kelyaha wuxuu ku socdaa heerar kala duwan iyadoo ku xiran nooca burada. Qaar waxay u koraan si tartiib ah waxayna ku ekaanayaan kelyaha, halka qaar kalena ay u dhaqmaan si ka sii daran. Fahamka xaaladda goor hore waxay ka caawisaa dhakhaatiirta inay doortaan qorshaha daaweynta ugu waxtarka badan.

 

Waa maxay Noocyada Kansarka Kelyaha?

Kansarka kelyuhu wuxuu u muuqdaa noocyo kala duwan, mid walbana wuxuu leeyahay hab-dhaqankiisa iyo habka daaweynta. Kiisaska intooda badani waxay saameeyaan dadka waaweyn, laakiin noocyada qaarkood ayaa sidoo kale ku dhaca carruurta.

 

  • Nadiifi Kansarka Unugyada Kelyaha ee Unugyada (RCC):Kani waa nooca ugu badan ee dadka waaweyn. Burooyinku waxay ka kooban yihiin unugyo cirro leh ama cad oo inta badan si fiican uga jawaaba qalliinka iyo daawaynta la beegsaday.
  • Kansarka Unugyada Kelyaha ee Papillary:Burooyinkani waxay sameeyaan saadaalin far u eg waxaana laga yaabaa inay si tartiib ah ama si adag u koraan, iyadoo ku xiran nooca hoose.
  • Kansarka Unugyada Kelyaha ee Chromophobe:Nooc aan caadi ahayn oo caadi ahaan si tartiib ah u koraya oo u janjeera inuu yeesho saadaal ka wanaagsan noocyada kale ee RCC.
  • Wilms Buro (Kansar kelyaha caruurnimada):Noocani wuxuu si gaar ah ugu muuqdaa carruurta yaryar wuxuuna si fiican uga jawaabaa isku darka qalliinka, kiimoterabiga, iyo shucaaca.
  • Burooyin naadir ah:Ururinta kansarka sanbabada, sarcoma kelyaha, iyo kansarka medullary waxay u dhacaan si aan badnayn laakiin badanaa waxay u baahan yihiin daaweyn dagaal badan.

Waa maxay Calaamadaha Kansarka Kelyaha?

Kansarka kelyuhu wuxuu inta badan ku soo baxaa aamusnaan, dad badanna waxay dareemaan calaamadaha marxaladaha dambe. Xaaladaha qaarkood, dhakhaatiirtu waxay ogaadaan burada si lama filaan ah inta lagu jiro baarista lagu sameeyay arrimaha aan la xiriirin.

 

  • Dhiiga Kaadi:Mid ka mid ah calaamadaha digniinta ugu horreeya waa casaan, casaan, ama kaadi midab leh oo ay keento dhiig-baxa buro.
  • Xanuun Joogto ah:Xanuun caajis ah ama xanuun fiiqan ayaa laga yaabaa inuu ka soo baxo dhabarka, dhinaca, ama caloosha hoose.
  • Miisaanka Dhimista Aan La Sharacin:Miisaanka degdega ah oo aan isbeddelin cunto ama jimicsi ayaa calaamad u ah koritaanka kansarka hoose.
  • Daal iyo Daciifnimo:Dadka ayaa laga yaabaa inay dareemaan daal marka uu jirkoodu la halgamayo maaraynta cudurka.
  • Buro ama Curo dhinaca:Shakhsiyaadka qaarkood waxay dareemaan barar adag meel u dhow gobolka kelyaha.
  • Xummad Aan La Xiriirin Infekshin:Qandho marmar ah oo aan lahayn sabab cad waxay ka soo muuqan kartaa xaaladaha horumarsan.
  • Dhiig-karka ama Dhiig-yarida:Burooyinka kelyaha ayaa laga yaabaa inay carqaladeeyaan soosaarka hoormoonka, taasoo keenta isbeddel ku yimaada cadaadiska dhiigga ama heerarka unugyada dhiigga cas.

Sidee Lagu Ogaaday Kansarka Kelyaha?

Dhakhaatiirta Oncologists waxay isticmaalaan baaritaanno isku dhafan iyo daraasado sawir-qaadis si ay u xaqiijiyaan kansarka kelyaha oo ay fahmaan inta uu horumarku gaadhay. Cilad-sheegid hore oo sax ah ayaa kaa caawinaysa hagidda daaweynta ugu waxtarka badan.

 

  • Tijaabada Dhiiga:Tijaabooyinku waxay qiimeeyaan shaqada kelyaha, hubi heerarka hemoglobin, waxayna raadiyaan calaamadaha shaqada xubnaha aan caadiga ahayn.
  • Falanqaynta Kaadi:Baadhitaannada kaadidu waxay caawiyaan in lagu ogaado dhiigga ama walxaha aan caadiga ahayn ee laga yaabo inay soo jeediyaan buro.
  • Ultrasound:Tijaabo badbaado leh oo toos ah oo inta badan lagu garto tuhunka shakiga ee kelyaha.
  • CT Scan ama MRI:Sawirka faahfaahsan wuxuu caawiyaa in la qiimeeyo cabbirka burada, booska, iyo suurtagalnimada faafitaanka xubnaha u dhow ama xididdada dhiigga. CT scans ayaa ah qalabka ugu badan ee loo isticmaalo diyaarinta.
  • Biopsy (Marka loo baahdo):Dhakhaatiirtu mararka qaarkood waxay qaadaan muunad yar oo unug ah si ay u xaqiijiyaan nooca kansarka, gaar ahaan marka natiijooyinka sawirku aanay caddayn ama marka la qorsheynayo daawaynta la beegsaday.
  • Sawirka Xabadka iyo Baadhista Lafaha:Tijaabooyinku waxay hubinayaan inay ku faafaan sambabada ama lafaha xaaladaha horumarsan.

Marka dhammaan natiijooyinka la helo, dhakhaatiirtu waxay go'aamiyaan heerka kansarka waxayna ku talinayaan qorshe daaweyn shakhsiyeed.

 

Waa Maxay Hababka Daawaynta Ugu Danbeeyay Ee Kansarka Kelyaha?

Daawaynta kansarka kelyuhu waxay ku xidhan tahay xajmiga burada, heerka, iyo fiditaanka. Dhakhaatiirtu waxay abuuraan qorshe shaqsiyeysan oo ay ku jiraan qalliin, dawooyin la bar tilmaameedsado, ama tallaalka difaaca jirka. Farsamooyinka casriga ahi waxay caawiyaan ilaalinta shaqada kelyaha iyo hagaajinta natiijooyinka muddada dheer.

 

Qalliin (Qayb ama Nephrectomy Radical)

Qalliinka ayaa weli ah daawaynta aasaasiga ah ee kansarka kelyaha ee hore iyo kuwa gudaha ah.

 

  • Nephrectomy qayb ahaanwaxay ka saartaa burada oo kaliya waxayna badbaadisaa kelyaha inteeda kale.
  • Nephrectomy xagjir ahwaxay ka saartaa kelyaha oo dhan haddii ay buro weyn tahay ama meel dhexe ku taal.

Labada ikhtiyaarba waxay ujeedadoodu tahay in gebi ahaanba la baabi'iyo kansarka iyada oo la ilaalinayo shaqada kelyaha mar kasta oo ay suurtagal tahay.

 

Qalliinka Laparoscopic ama Robotic

Hababka ugu yar ee soo gelitaanka waxay isticmaalaan jeexyo yaryar iyo qalab sare. Bukaan-socodka ayaa si dhakhso ah u bogsada, waxay dareemaan xanuun yar, waxayna ku noqdaan hawl maalmeedka si degdeg ah. Qalliinka robotku wuxuu bixiyaa saxsanaan sare, gaar ahaan burooyinka kakan.

 

Farsamooyinka Ablation

Marka qaliinku aanu ku haboonayn, takhaatiirtu waxay isticmaalaan habab la beegsaday si ay u burburiyaan burada:

 

  • Cyoablationwaxay qaboojisaa unugyada kansarka.
  • Soo noqnoqoshada raadiyaha (RFA)waxay isticmaashaa kulayl si ay u disho burada.

Hababkani waxay si fiican ugu shaqeeyaan burooyinka yaryar iyo bukaanada aan samayn karin qalliin weyn.

 

Daawaynta La Beegsado

Daawooyinka la beegsaday waxay xannibaan dariiqyo gaar ah oo unugyada kansarku u adeegsadaan inay koraan. Daawooyinkani waxay caawiyaan xakameynta kansarka kelyaha ee horumarsan ama metastatic waxayna yareyn karaan burooyinka ka hor ama ka dib qaliinka.

 

Immunotherapy

Immunotherapy waxay xoojisaa habka difaaca jidhka si ay si waxtar leh u weerarto unugyada kansarka. Waxay door muhiim ah ka ciyaartaa xakamaynta cudurrada horumaray ama soo noqnoqda.

Hel qorshe daaweyn oo bilaash ah

Dooro Dalka
  • INIndia (भारत)+91
  • USUnited States of America+1
  • AFAfghanistan (‫افغانستان‬‎)+93
  • ALAlbania (Shqipëri)+355
  • DZAlgeria (‫الجزائر‬‎)+213
  • ASAmerican Samoa+1
  • ADAndorra+376
  • AOAngola+244
  • AIAnguilla+43
  • AGAntigua and Barbuda+1
  • ARArgentina+54
  • AMArmenia (Հայաստան)+374
  • AWAruba+297
  • AUAustralia+61
  • ATAustria (Österreich)+43
  • AZAzerbaijan (Azərbaycan)+994
  • BSBahamas+1
  • BHBahrain (‫البحرين‬‎)+973
  • BDBangladesh (বাংলাদেশ)+880
  • BBBarbados+1
  • BYBelarus (Беларусь)+375
  • BEBelgium (België)+32
  • BZBelize+501
  • BJBenin (Bénin)+229
  • BMBermuda+1
  • BTBhutan (འབྲུག)+975
  • BOBolivia (Plurinational State of)+591
  • BABosnia and Herzegovina (Босна и Херцеговина)+387
  • BWBotswana+267
  • BRBrazil (Brasil)+55
  • IOBritish Indian Ocean Territory+246
  • VGVirgin Islands (British)+1
  • VIVirgin Islands (U.S.)+1
  • BNBrunei Darussalam+673
  • BGBulgaria (България)+359
  • BFBurkina Faso+226
  • BIBurundi (Uburundi)+257
  • KHCambodia (កម្ពុជា)+855
  • CMCameroon (Cameroun)+237
  • CACanada+1
  • CVCape Verde (Kabu Verdi)+238
  • KYCayman Islands+1
  • CFCentral African Republic (République centrafricaine)+236
  • CLChile+56
  • CNChina (中国)+86
  • COColombia+57
  • KMComoros (‫جزر القمر‬‎)+269
  • CGCongo (DRC) (Jamhuri ya Kidemokrasia ya Kongo)+242
  • CDCongo (Republic) (Congo-Brazzaville)+243
  • CKCook Islands+682
  • CRCosta Rica+506
  • HRCroatia (Hrvatska)+385
  • CUCuba+53
  • CYCyprus (Κύπρος)+357
  • CZCzech Republic (Česká republika)+420
  • DKDenmark (Danmark)+45
  • DJDjibouti+253
  • DMDominica+1
  • DODominican Republic (República Dominicana)+1
  • ECEcuador+593
  • EGEgypt (‫مصر‬‎)+20
  • SVEl Salvador+503
  • GQEquatorial Guinea (Guinea Ecuatorial)+240
  • EREritrea+291
  • EEEstonia (Eesti)+372
  • ETEthiopia+251
  • FKFalkland Islands (Islas Malvinas)+500
  • FOFaroe Islands (Føroyar)+298
  • FJFiji+679
  • FIFinland (Suomi)+358
  • FRFrance+33
  • GFFrench Guiana (Guyane française)+594
  • PFFrench Polynesia (Polynésie française)+689
  • GAGabon+241
  • GMGambia+220
  • GEGeorgia (საქართველო)+995
  • DEGermany (Deutschland)+49
  • GHGhana (Gaana)+233
  • GIGibraltar+350
  • GRGreece (Ελλάδα)+30
  • GLGreenland (Kalaallit Nunaat)+299
  • GDGrenada+1
  • GPGuadeloupe+590
  • GUGuam+1
  • GTGuatemala+502
  • GNGuinea (Guinée)+224
  • GWGuinea-Bissau (Guiné Bissau)+245
  • GYGuyana+592
  • HTHaiti+509
  • VAHoly See+39
  • HNHonduras+504
  • HKHong Kong (香港)+852
  • HUHungary (Magyarország)+36
  • ISIceland (Ísland)+354
  • IDIndonesia+62
  • CICôte d'Ivoire+225
  • IRIran (‫ایران‬‎)+98
  • IQIraq (‫العراق‬‎)+964
  • IEIreland+353
  • ILIsrael (‫ישראל‬‎)+972
  • ITItaly (Italia)+39
  • JMJamaica+1
  • JPJapan (日本)+81
  • JOJordan (‫الأردن‬‎)+962
  • KZKazakhstan (Казахстан)+7
  • KEKenya+254
  • KIKiribati+686
  • KWKuwait (‫الكويت‬‎)+965
  • KGKyrgyzstan (Кыргызстан)+996
  • LALaos (ລາວ)+856
  • LVLatvia (Latvija)+371
  • LBLebanon (‫لبنان‬‎)+961
  • LSLesotho+266
  • LRLiberia+231
  • LYLibya (‫ليبيا‬‎)+218
  • LILiechtenstein+423
  • LTLithuania (Lietuva)+370
  • LULuxembourg+352
  • MOMacau (澳門)+853
  • MKMacedonia (the former Yugoslav Republic of)+389
  • MGMadagascar (Madagasikara)+261
  • MWMalawi+265
  • MYMalaysia+60
  • MVMaldives+960
  • MLMali+223
  • MTMalta+356
  • MHMarshall Islands+692
  • MQMartinique+596
  • MRMauritania (‫موريتانيا‬‎)+222
  • MUMauritius (Moris)+230
  • YTMayotte+262
  • MXMexico (México)+52
  • FMMicronesia (Federated States of)+691
  • MDMoldova (Republica Moldova)+373
  • MCMonaco+377
  • MNMongolia (Монгол)+976
  • MEMontenegro (Crna Gora)+382
  • MSMontserrat+1
  • MAMorocco (‫المغرب‬‎)+212
  • MZMozambique (Moçambique)+258
  • MMMyanmar (Burma) (မြန်မာ)+95
  • NANamibia (Namibië)+264
  • NRNauru+674
  • NPNepal (नेपाल)+977
  • NLNetherlands (Nederland)+31
  • NCNew Caledonia (Nouvelle-Calédonie)+687
  • NZNew Zealand+64
  • NINicaragua+505
  • NENiger (Nijar)+227
  • NGNigeria+234
  • NUNiue+683
  • NFNorfolk Island+672
  • KPNorth Korea (조선 민주주의 인민 공화국)+850
  • MPNorthern Mariana Islands+1
  • NONorway (Norge)+47
  • OMOman (‫عُمان‬‎)+968
  • PKPakistan (‫پاکستان‬‎)+92
  • PWPalau+680
  • PSPalestine (‫فلسطين‬‎)+970
  • PAPanama (Panamá)+507
  • PGPapua New Guinea+675
  • PYParaguay+595
  • PEPeru (Perú)+51
  • PHPhilippines+63
  • PLPoland (Polska)+48
  • PTPortugal+351
  • PRPuerto Rico+1
  • QAQatar (‫قطر‬‎)+974
  • XKRepublic of Kosovo+381
  • RERéunion (La Réunion)+262
  • RORomania (România)+40
  • RURussia (Россия)+7
  • RWRwanda+250
  • BLSaint Martin (Saint-Martin (partie française))+590
  • SHSaint Helena, Ascension and Tristan da Cunha+290
  • KNSaint Kitts and Nevis+1
  • LCSaint Lucia+1
  • MFSaint Martin (French part)+590
  • PMSaint Pierre and Miquelon+508
  • VCSaint Vincent and the Grenadines+1
  • WSSamoa+685
  • SMSan Marino+378
  • STSão Tomé and Príncipe (São Tomé e Príncipe)+239
  • SASaudi Arabia (‫المملكة العربية السعودية‬‎)+966
  • SNSenegal (Sénégal)+221
  • RSSerbia (Србија)+381
  • SCSeychelles+248
  • SLSierra Leone+232
  • SGSingapore+65
  • SKSlovakia (Slovensko)+421
  • SISlovenia (Slovenija)+386
  • SBSolomon Islands+677
  • SOSomalia (Soomaaliya)+252
  • ZASouth Africa+27
  • KRSouth Korea (대한민국)+82
  • ESSpain+34
  • LKSri Lanka (ශ්‍රී ලංකාව)+94
  • SDSudan (‫السودان‬‎)+249
  • SRSuriname+597
  • SZSwaziland+268
  • SESweden (Sverige)+46
  • CHSwitzerland (Schweiz)+41
  • SYSyria (‫سوريا‬‎)+963
  • TWTaiwan (台灣)+886
  • TJTajikistan+992
  • TZTanzania, United Republic of+255
  • THThailand+66
  • TLTimor-Leste+670
  • TGTogo+228
  • TKTokelau+690
  • TOTonga+676
  • TTTrinidad and Tobago+1
  • TNTunisia (‫تونس‬‎)+216
  • TRTurkey (Türkiye)+90
  • TMTurkmenistan+993
  • TCTurks and Caicos Islands+1
  • TVTuvalu+688
  • UGUganda+256
  • UAUkraine (Україна)+380
  • AEUnited Arab Emirates (‫الإمارات العربية المتحدة‬‎)+971
  • GBUnited Kingdom of Great Britain and Northern Ireland+44
  • UYUruguay+598
  • UZUzbekistan (Oʻzbekiston)+998
  • VUVanuatu+678
  • VEVenezuela (Bolivarian Republic of)+58
  • VNVietnam (Việt Nam)+84
  • WFWallis and Futuna (Wallis-et-Futuna)+681
  • YEYemen (‫اليمن‬‎)+967
  • ZMZambia+260
  • ZWZimbabwe+263

Qiyaastii Daaweynta Kansarka Kelyaha gudaha Hindiya

Immisa Qiimaha Daawaynta Kansarka Kelyaha gudaha Hindiya?

Qiimaha daaweynta kansarka kelyaha ee Hindiya way kala duwan tahay iyadoo ku xiran heerka cudurka, daaweynta la doortay, iyo khibradda isbitaalka. Qiimaha guud ee daawaynta kansarka kelyaha ee Hindiya way u dhaxaysaa$4,000 ilaa $18,000, oo ku salaysan isku-darka qalliinka, daawooyinka, iyo daryeelka taageerada ee loo baahan yahay. Tani waa qiyaastii3.3 lakh ilaa 15 lakh.

 

Kala-baxa Qiimaha Nooca Daaweynta

Habka Daawaynta

Qiimaha (USD)

Qiimaha (INR)

Nephrectomy qayb ah$4,500 – $7,0003,70,000 - ₹ 5,80,000
Nephrectomy Radical$4,000 – $6,5003,30,000 - ₹ 5,40,000
Laparoscopic / Robotic Nephrectomy$6,000 – $10,0004,90,000 - ₹ 8,20,000
Cyoablation / RFA$3,500 – $6,0002,90,000 - ₹ 5,00,000
Daawaynta la beegsaday (bishii)$1,000 – $4,00080,000 - ₹ 3,30,000
Immunotherapy (wareeg kasta)$2,500 – $5,0002,00,000 - ₹ 4,10,000
Daaweynta Shucaaca$1,200 – $3,0001,00,000 - ₹ 2,50,000

Kala-baxa Qiimaha Marxaladda Kansarka

Marxaladda Kansarka

Qiimaha caadiga ah (USD)

Qiimaha caadiga ah (INR)

Daawaynta Laga Yaabo

Marxaladda 1$4,000 – $8,0003,30,000 - ₹ 6,60,000Qalliin (qayb/nephrectomy xagjir ah)
Marxaladda 2$5,000 – $10,0004,10,000 - ₹ 8,20,000Qalliinka + sawir-qaadista
Marxaladda 3$8,000 – $15,0006,60,000 - ₹ 12,30,000Qalliin + daawaynta la beegsaday
Marxaladda 4$12,000 – $25,000+9,80,000 - ₹ 20,50,000+Immunotherapy + daawaynta la beegsaday + daryeelka palliative

Maxaa Kharashku Ku Jira Oo Ka Reebay?

Fahamka qaab dhismeedka kharashku wuxuu ka caawiyaa bukaanka inay si cad u qorsheeyaan safarkooda daawaynta. Isbitaaladu waxay qeexayaan waxa ku jira xirmada iyo waxa laga yaabo inay u baahdaan kharashyo dheeraad ah oo ku salaysan baahida shakhsi ahaaneed.

 

Waxa Qiimaha Ku Jira

Badi xirmooyinka daawaynta ee kansarka kelyaha ee Hindiya waxay daboolaan qaybaha caafimaad ee muhiimka ah ee loo baahan yahay ogaanshaha saxda ah iyo daaweynta waxtarka leh:

 

  • Kharashyada dhakhtarka qalliinka ee nephrectomy ama hababka la xidhiidha
  • Kharashaadka tiyaatarka hawlgalka, oo ay ku jiraan qalabka horumarsan
  • Suuxinta iyo la socodka xilliga qalliinka
  • Joogitaanka isbitaalka (Qolka caadiga ah ama qaybta qaybta)
  • Tijaabooyin dhiig oo joogto ah iyo sawirka aasaasiga ah inta lagu jiro isbitaalka
  • Daawooyinka caadiga ah, maaraynta xanuunka, iyo antibiyootiga
  • Daryeelka kalkaalinta iyo la socodka qalliinka kadib
  • La-talinta dabagalka inta lagu jiro isbitaalka

Ku darisyadani waxay xaqiijinayaan qalliin badbaado leh, soo kabasho hore, iyo daryeel bukaan-jiif oo dhammaystiran.

 

Maxaa Kharashka Ka Reeban

Qaybaha qaar way ku kala duwan yihiin bukaan-socodka waxaana badanaa si gaar ah loo dallacaa:

 

  • Sawir-qaadista sare, sida PET-CT, MRI, ama baarista lafaha
  • Joogitaanka cusbitaalka oo dheeraad ah, haddii ay dhibaatooyin soo baxaan
  • Daawaynta la beegsaday iyo wareegyada difaaca jirka ee ka baxsan daawaynta hore
  • Qalab gaar ah oo la geliyo ama la tuuro, haddii la isticmaalo xilliga qalliinnada adag
  • Daawooyinka dheecaanka ka dib iyo kaabista nafaqada
  • Booqashooyinka daba-galka ah ee muddada-dheer iyo shaybaadhka
  • Baxnaaninta ama daaweynta jireed, haddii loo baahdo
  • Safarka, fiisaha, iyo hoyga qoysaska caalamiga ah

Isbitaaladu waxay bixiyaan qiyaas shaqsiyeysan si bukaanadu u qorsheeyaan daawayntooda oo ay ugu nastaan.

 

Maxay yihiin Qodobbada Saameynaya Qiimaha Daaweynta Kansarka Kelyaha ee Hindiya?

Wadarta qiimaha daawaynta kansarka kelyaha way kala duwan tahay iyadoo ku salaysan baahiyaha caafimaad, doorashooyinka daawaynta, iyo walxaha la xidhiidha cisbitaalka. Xaalad kasta oo bukaan ah waa mid gaar ah, sidaas darteed dhakhaatiirtu waxay u qaabeeyaan daawaynta si loo hubiyo natiijooyinka ugu wanaagsan ee suurtogalka ah.

 

  • Marxaladda Kansarka:Kharashyadu way kordhaan marka uu cudurku sii socdo sababtoo ah marxaladaha dambe waxay u baahan yihiin daawayn badan, sida daroogooyinka la beegsaday, immunotherapy, iyo baaritaanno dheeraad ah.
  • Nooca daawaynta ee la doortay:Qalliinku guud ahaan waa ka qaalisan yahay, halka daawaynta la beegsaday iyo daawaynta difaaca jirka ay si weyn u kordhiyeen wadarta qiimaha wareegyada socda awgeed.
  • Qalliinka Kakanaanta:Burooyinka waaweyn ama meel dhexe ku yaal waxay u baahan karaan waqti dheer oo hawlgelin ah, caawinaad roboti ah, ama dib-u-dhis horumarsan, kaas oo saameeya qiimaha.
  • Qeybta Isbitaalka:Isbitaalada qiimaha leh ee leh nidaamyada robotka, ICU-yada-dhamaadka sare leh, iyo waaxyada kansarka sare ee kansarka sida caadiga ah wax ka badan.
  • Khabiirka Dhakhtarka:Dhakhaatiirta Oncologists iyo dhakhaatiirta qalliinka ee leh waayo-aragnimo ballaadhan, takhasus-hoosaad, ama tababar caalami ah ayaa laga yaabaa inay leeyihiin kharashyo xirfadeed oo sarreeya.
  • Baahida Joogitaanka ICU:Bukaanka qaba dhibaatooyin ama cuduro horumaray ayaa mararka qaarkood u baahan daryeelka ICU ee qalliinka kadib, taasoo kordhinaysa kharashka isbitaal dhigista.
  • Tirada Baadhista Dabagalka ah:Baadhitaannada CT-ga, MRI-yada, ama daraasadaha PET-CT ayaa lagama maarmaan u ah la-socodka jawaabta daaweynta waxaana laga yaabaa inay si weyn u saameeyaan kharashyada guud.
  • Xaaladaha Caafimadka Isku-dhafan:Sonkorowga, dhiig-karka, kelyaha oo aan shaqayn, ama arrimaha wadnaha ayaa sii dheerayn kara isbitaalka waxayna kordhin karaan baahida daawada.

Waa maxay Kharashka Caaqilka Magaalada ee Daaweynta Kansarka Kelyaha ee Hindiya?

Qiimaha daaweynta kansarka kelyaha ayaa ku kala duwan magaalooyinka waaweyn ee Hindiya sababtoo ah kala duwanaanshaha kaabayaasha isbitaallada, khibradda dhakhtarka qalliinka, iyo helitaanka tignoolajiyada horumarsan sida qalliinka robotka iyo daaweynta difaaca jirka.

Hoos waxaa ah isbarbardhigga magaalada-xikmadda leh ee qiyaas ahaan si looga caawiyo bukaannada inay si waxtar leh u qorsheeyaan miisaaniyaddooda daawaynta.

 

Magaalada

Celceliska Qiimaha (USD)

Qiyaastii Qiimaha (INR)

New Delhi$4,500 – $18,0003,70,000 - ₹ 15,00,000
Mumbai$4,800 – $19,0004,00,000 - ₹ 15,70,000
Chennai$4,000 – $16,0003,30,000 - ₹ 13,20,000
Bangalore$4,200 – $17,0003,50,000 - ₹ 14,00,000
Hyderabad$4,000 – $16,5003,30,000 - ₹ 13,50,000
  • New Delhi iyo Mumbai:Magaalooyinkani waxay bixiyaan qaar ka mid ah xarumaha kansarka ugu horumarsan, unugyada qalliinka robotiga ah, iyo kooxaha culuumta badan, taasoo keentay kharash yar oo sarreeya.
  • Chennai iyo Hyderabad:Labada magaaloba waxay bixiyaan daryeel kansar oo heer sare ah, oo leh dhakhaatiir khibrad leh iyo shucaac xooggan iyo barnaamijyo caafimaad oncology, oo qiimo tartan leh.
  • Bangalore:Waxaa loo yaqaan isbitaallada casriga ah iyo tas-hiilaadka sawirada horumarsan, Bangalore waxay bixisaa qiime isku dheelitiran oo leh daryeel tayo sare leh oo loogu talagalay bukaannada caalamiga ah.

Waa maxay Isbarbardhigga Qiimaha Wadanku ee Daawaynta Kansarka Kelyaha?

Qiimaha daaweynta kansarka kelyaha ayaa si weyn u kala duwan adduunka oo dhan. Hindiya waxay bixisaa daryeelka kansarka kansarka oo horumarsan oo qayb yar ka ah qiimaha lagu arko dalalka reer galbeedka. Waxay dalka ka dhigaysaa meesha ay doorbidayaan bukaannada caalamiga ah ee doonaya daawayn jaban oo tayo sare leh.

Dalka

Celceliska Qiimaha (USD)

Hindiya$4,000 – $18,000
Maraykanka$30,000 – $70,000
Boqortooyada Ingiriiska$20,000 – $50,000
UAE$15,000 – $35,000
Thailand$8,000 – $20,000

Hindiya waxay bixisaa kharash daawaynta60-80% hoosemarka loo eego kuwa ku sugan US, UK, iyo UAE, iyadoo la siinayo marin u helka qalliinka robotic-ka sareeyo, waaxyada kansarka casriga ah, iyo khabiiro caalami ah oo tababaran. Qiimaha la awoodi karo ma dhimayo tayada; taa beddelkeeda, waxay ka tarjumaysaa kaabayaasha daryeelka caafimaadka hufan ee Hindiya iyo nidaamyada hawlgalka kharash-ool ah.

 

Waa maxay Habka Soo kabashada ee Daaweynta Kansarka Kelyaha?

  • Soo kabashada Qalitaanka Kadib (Qayb ama Nephrectomy Radical):Bukaanka lagu sameeyo nephrectomy inta badan waxay joogaan isbitaalka3-5 maalmood. Socodku wuxuu bilaabmaa 24-ka saacadood ee ugu horreeya gudahooda si loo hagaajiyo wareegga iyo taageerada bogsashada. Shakhsiyaadka badankoodu waxay ku soo noqdaan waxqabadyada iftiinka gudaha2-3 toddobaad, halka soo kabashada buuxda ay qaadan karto ilaa6 toddobaad. Hababka Robotic iyo Laparoscopic waxay bixiyaan bogsiin degdeg ah iyo hoos u dhac la'aan.
  • Soo kabashada inta lagu jiro daawaynta la beegsaday:Daawooyinka la beegsaday uma baahna in isbitaal la seexiyo. Bukaanku waxay sii wataan hawl maalmeedka inta ay ka qayb qaadanayaan dabagalka qorshaysan. Dhakhaatiirtu waxay la socdaan cadaadiska dhiigga, shaqada kelyaha, iyo waxyeellooyinka si ay u hagaajiyaan qiyaasta marka loo baahdo.
  • Soo kabashada Inta lagu jiro Immunotherapy:Wareegyada daawaynta waxaa la bixiyaa dhowrkii toddobaadba mar. Bukaan-socodka ayaa laga yaabaa inay dareemaan daal fudud ama calaamadaha hargabka oo kale ka dib wareeg kasta, laakiin saameyntani waxay caadi ahaan si dhakhso ah u soo fiicnaataa. Korjoogteynta joogtada ahi waxay xaqiijisaa daawaynta badbaadada iyo waxtarka leh.

Waa maxay heerka guusha ee Daaweynta Kansarka Kelyaha ee Hindiya?

Heerka guusha ee daaweynta kansarka kelyaha waxay ku xiran tahay heerka cudurka, bayoolajiga buro, iyo jawaabta daawaynta. Horumarrada laga sameeyay qalliinka, daawaynta la beegsaday, iyo daawaynta difaaca jirka ayaa si weyn u wanaajiyay badbaadada iyo natiijooyinka muddada dheer adduunka oo dhan.

 

Heerarka guusha ee heerka

  • Marxaladda 1:Bukaanjiifka badankoodu waxay leeyihiin natiijooyin aad u fiican, oo lehHeerarka badbaadada 5-sano ee 85-95%qaliinka ka dib. Burooyinka goor hore la ogaado inta badan ma soo noqdaan.
  • Marxaladda 2:Heerarka badbaadadu waxay u dhexeeyaan75-85%, gaar ahaan marka takhaatiirta qalliinka ay ka saaraan burada oo dhan iyagoo leh meelo cadcad.
  • Marxaladda 3:Heerka guushu way kala duwan tahay50-70%, iyadoo ku xidhan ka-qaybgalka qanjidhada qanjidhada iyo jawaabta daaweynta habdhiska.
  • Marxaladda 4:Kiisaska horumarsan ayaa lehHeerarka badbaadada 5-sano ee 15-30%, laakiin immunotherapy casriga ah iyo daawooyinka la beegsaday waxay caawiyaan bukaanno badan inay ku noolaadaan nolol tayo wanaagsan leh.

Saamaynta Dawooyinka Casriga ah

  • Qalliinnada Robotic iyo Laparoscopicyaree dhibaatooyinka oo dedejiya bogsiinta.
  • Daawaynta la beegsadaykoritaanka burada oo yaraada oo nabarrada waxay yareeyaan marka qalliinku aanu suurtogal ahayn.
  • Immunotherapywaxay kordhisaa awoodda jidhka ee lagu xakameynayo cudurrada horumaray.
  • Dabagal joogto ahcaawin in la ogaado soo noqoshada goor hore, hagaajinta natiijooyinka muddada dheer.

Guud ahaan, ogaanshaha hore iyo isku darka daaweynta casriga ah ayaa siinaya bukaanada fursad adag oo soo kabasho waarta.

 

Maxaad Hindiya ugu dooratay Daaweynta Kansarka Kelyaha?

Hindiya waxay noqotay meesha loo doorbido MVT ee daaweynta kansarka kelyaha sababtoo ah daryeelka sare ee kansarka, khabiiro khibrad leh, iyo awood u yeelashada. Bukaan-socodka ayaa helaya daawayn heer caalami ah oo leh fiiro gaar ah iyo waqti sugitaan oo yar.

 

  • Dhakhaatiirta Kansarka ee Khibrada leh iyo Dhakhaatiirta Qalliinka:Hindiya waxay leedahay takhaatiir aad u tababaran oo ku takhasusay urologists, dhakhaatiirta qalliinka robotka, iyo dhakhaatiirta kansarka oo si joogto ah u maamula kiisaska kansarka kelyaha ee adag.
  • Farsamada Qalliinka Sare:Isbitaalo badan ayaa bixiya nephrectomy-caawin-roobotik ah, qalliinka laparoscopic, iyo farsamooyinka ciribtirka casriga ah. Hababkani waxay yareeyaan xanuunka, soo kabashada soo gaabiyaan, waxayna ilaaliyaan shaqada kelyaha.
  • Daryeelka Kansarka oo Dhameystiran:Kooxaha edbinta kala duwan, oo ay ku jiraan dhakhaatiirta kansarka, raajo-yaqaannada, dhakhaatiirta cudurrada, iyo khabiirada nafaqada, waxay si wadajir ah u shaqeeyaan si ay u abuuraan xeelado daawaynta shakhsi ahaaneed ee bukaan kasta.
  • Kaabayaasha Isbitaalka Casriga ah:Isbitaaladu waxay bixiyaan sawiro horumarsan, xarumo kansar oo u go'ay, taageerada ICU, iyo qolal qalliin oo si fiican u qalabaysan si loo hubiyo badbaado, daaweyn aan xidhiidh lahayn.
  • Kooxaha Caafimaadka ku hadla Ingiriisiga:Dhakhaatiirta, kalkaaliyayaasha caafimaadka, iyo isku-duwayaasha ayaa si faseexa ugu wada xidhiidha Ingiriisi, iyaga oo la tashiyo iyo dabagal ku samaynaya bukaanada caalamiga ah.

Waa maxay Adeegyada Bukaanka Caalamiga ah ee looga Heli karo Daaweynta Kansarka Kelyaha ee Hindiya?

Hindiya waxay bixisaa nidaam taageero oo habaysan oo loogu talagalay bukaannada caalamiga ah si loo hubiyo waayo-aragnimada siman laga bilaabo wakhtiga ay qorsheynayaan safarkooda ilaa dhamaystirka daaweyntooda oo ay ku noqdaan dalkooda. Isbitaaladu waxay magacaabaan isuduwayaal u go'an oo ku haga bukaanka iyo qoysaska marxalad kasta oo daryeel ah.

 

  • Caawinta Fiisaha Caafimaadka:Isbitaaladu waxay bixiyaan waraaqaha martiqaadka fiisaha, qiyaasaha daawaynta, iyo dukumentiyada loo baahan yahay si ay uga caawiyaan bukaanada inay helaan fiisaha caafimaadka si dhakhso leh oo fudud.
  • Qaadista iyo Soo Dejinta Madaarka:Xarumo badan ayaa bixiya gaadiid bilaash ah ama horay loo sii diyaariyay, hubinta safarka badbaadada leh ee u dhexeeya garoonka diyaaradaha, isbitaalka, iyo hoyga.
  • Taageerada hoyga:Isku-duwayaasha ayaa ka caawiya bukaanada iyo qoysaska inay helaan huteelada u dhow, guryo adeega leh, ama guryaha martida ee ku habboon miisaaniyadooda iyo baahidooda raaxada.
  • Adeegga Turjumaada iyo Luuqadda:Isbitaaladu waxay bixiyaan tarjumaano Carabi, Faransiis, Ruush, Afrikaan, iyo Koonfur-bari Aasiya luqadaha si loo hubiyo wada-xiriir hufan inta lagu jiro ogaanshaha iyo daaweynta.
  • Ballamaha Mudnaanta leh iyo Jadwalka Socodka Degdegga ah:Bukaannada caalamiga ah waxay si degdeg ah u helaan la-talin, baaritaanno ogaanshaha, iyo jadwalka qalliinka, taasoo ka caawinaysa inay bilaabaan daahid la'aan.
  • Daah-furnaanta biilasha iyo Taageerada Lacag-bixinta:La-taliyayaasha maaliyadeed waxay si cad u sharxaan kharashka daawaynta waxayna taageeraan hababka lacag-bixinta caalamiga ah, oo ay ku jiraan xawilaadda siliga, kaararka deynta, iyo dukumentiyada caymiska ee la ansixiyay.
  • Dabagalka Daawaynta Kadib:Daawaynta ka dib, bukaanku waxay helayaan warbixino caafimaad oo dhamaystiran iyo helitaanka wada-tashiga daryeelka iyo la socodka joogtada ah ee dalkooda hooyo.

Daaweynta Kansarka Kelyaha Isbarbardhigga Qiimaha Dal ahaan

Isbarbar dhig bogga

Baaddiye Kala duwanaanshaha qiimaha (USD) Kaydinta suurtagalka ah Waxqabad
HindiyaQul-qulQiimaha ugu fiican
$4,000 - $18,000 Soo xigasho

Xusuusin: Kharashaadka ayaa ku kala duwanaan kara iyadoo lagu saleynayo doorashada isbitaalka, nooca qolka, adeegyada dheeraadka ah, iyo baahiyaha caafimaad ee shaqsiyadeed.

Cisbitaalada hogaaminaya Daaweynta Kansarka Kelyaha gudaha Hindiya

Park Medical Bahcelievler Hospital

Istanbul, Turkiga
Multi Specialty
Aasaasay 2007
242 Sariiraha

Medical Park Bahcelievler Hospital waa cisbitaal la aqoonsan yahay JCI oo leh 242 sariirood oo ku yaal Istanbul, oo la aasaasay 2007. Ku faafaya 33,00...

Aqoonsado
Joint Commission International (JCI)
Gadawiya xarumaha
+11

Hisar Intercontinental Hospital, Istanbul

Istanbul, Turkiga
Multi Specialty
Aasaasay 2005
212 Sariiraha

Cisbitaalka Hisar Intercontinental Hospital ee Istanbul waa JCI-ay aqoonsantahay, cusbitaal gaar ah oo leh 212 sariirood oo leh 35,000 mitir oo laba j...

Aqoonsado
Joint Commission International (JCI)
Gadawiya xarumaha
+11

Isbitaalka Medipol Bahçelievler

Istanbul, Turkiga
Multi Specialty
Aasaasay 2022
441 Sariiraha

Medipol Bahçelievler Hospital waa cisbitaal gaar loo leeyahay oo leh 441 sariirood oo ku yaala Istanbul oo bilaabay hawlgal bishii May 2022. Oo dabool...

Aqoonsado
Joint Commission International (JCI)
Gadawiya xarumaha
+11

Nidaamyada la midka ah

Chemotherapy gudaha Hindiya

1,200 USD to 6,000 USD

Immunotherapy gudaha Hindiya

1,800 USD to 4,500 USD

Shucaaca-Raaca La Habeeyay (IMRT) gudaha Hindiya

3,000 USD to 7,200 USD

Daaweynta Kansarka Caloosha gudaha Hindiya

3,000 USD to 12,000 USD

Daaweynta Kansarka Maskaxda gudaha Hindiya

6,500 USD to 15,000 USD

Daaweynta Kansarka Afka gudaha Hindiya

3,500 USD to 8,000 USD

Daaweynta Kansarka Ovarian-ka gudaha Hindiya

3,800 USD to 8,000 USD

Warqad maqas

Caafimaad ahaan waxaa dib u eegayDr. Priya Tiwari
Dib-u-eegistii u dambaysayJune 2026

Dr. Priya Tiwari is a renowned medical oncologist trained at the prestigious All India Institute of Medical Sciences (AIIMS). She specializes in comprehensive cancer care and is committed to deliver... Akhri wax dheeraad ah

Qorto

All
Dr. Riya Shree

Madaxa - Adeegyada Bukaanka Caalamiga ah

Madaxa - Adeegyada Bukaanka Caalamiga ah Caafimaadka iyo Caafimaadka Qoonaq
Daaweeye kiliinikada ah

Dr. Riya Shree waa daaweeye kiliinikada ah oo ku dhameysatay tababarkeedii Cusbitaalka Mata Chanan Devi, New Delhi, iyada oo khibrad gacan ka helaysa daryeelka bukaanka iyo baxnaaninta. Waxay ka soo ... Akhri wax dheeraad ah

Websaydhkeenu wuxuu adeegsadaa cookies. Qaanuunka Arrimaha Khaaska ah.